Literature DB >> 12089350

Characterization of a new upstream GnRH receptor promoter in human ovarian granulosa-luteal cells.

Chi Keung Cheng1, Chung Man Yeung, Billy K C Chow, Peter C K Leung.   

Abstract

GnRH has been implicated as an important local autocrine and paracrine factor in regulating ovarian function. However, to date, the transcriptional regulation of GnRH receptor (GnRHR) gene in human ovary remains poorly understood. Here we report the characterization of a new upstream promoter for the GnRHR gene in human granulosa-luteal cells. Using progressive deletion analysis, a region between nucleotide -1300 and -1018 (relative to the translation start site) was shown to exhibit the highest promoter activities in two immortalized human granulosa-luteal cell lines, SVOG-4o and SVOG-4m. Two putative CCAAT/enhancer binding protein (C/EBP) motifs and one GATA motif were identified within this region. Mutational studies showed that these three motifs cooperated synergistically to regulate GnRHR gene transcription in the granulosa cells but not in other cell types including human ovarian carcinoma OVCAR-3, human embryonic kidney-293 (HEK-293) and mouse pituitary gonadotrope-derived alphaT3-1 cells. Surprisingly, by competitive EMSAs, we found that an Oct-1 consensus sequence was able to inhibit protein complex formation with the distal C/EBP motif, suggesting a possible cross-talk between the Oct-1 transcription factor and this C/EBP motif. Taken together, our results strongly indicate a role of the C/EBP and GATA motifs in regulating GnRHR gene transcription in human granulosa-luteal cells and further suggest that tissue-specific expression of human GnRHR gene is mediated by differential promoter usage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089350     DOI: 10.1210/mend.16.7.0869

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.

Authors:  Yannis Prapas; Konstantinos Ravanos; Stamatios Petousis; Yannis Panagiotidis; Achilleas Papatheodorou; Chrysoula Margioula-Siarkou; Assunta Iuliano; Giuseppe Gullo; Nikos Prapas
Journal:  J Assist Reprod Genet       Date:  2017-08-03       Impact factor: 3.412

Review 2.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

3.  Silencing of Fshr occurs through a conserved, hypersensitive site in the first intron.

Authors:  Brian P Hermann; Leslie L Heckert
Journal:  Mol Endocrinol       Date:  2005-04-07

4.  POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP.

Authors:  Peixiang Wang; Qinghua Wang; Jane Sun; Jing Wu; Hang Li; Nina Zhang; Yachi Huang; Brenda Su; Ren-ke Li; Ling Liu; Yi Zhang; Harry P Elsholtz; Jim Hu; Herbert Y Gaisano; Tianru Jin
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

5.  Activity of the porcine gonadotropin-releasing hormone receptor gene promoter is partially conferred by a distal gonadotrope specific element (GSE) within an upstream enhancing region, two proximal GSEs and a retinoid X receptor binding site.

Authors:  Rebecca A Cederberg; Jacqueline E Smith; Emily A McDonald; Chanho Lee; Amy R Perkins; Brett R White
Journal:  Reprod Biol Endocrinol       Date:  2015-05-17       Impact factor: 5.211

6.  Divergent activity of the gonadotropin-releasing hormone receptor gene promoter among genetic lines of pigs is partially conferred by nuclear factor (NF)-B, specificity protein (SP)1-like and GATA-4 binding sites.

Authors:  Emily A McDonald; Jacqueline E Smith; Rebecca A Cederberg; Brett R White
Journal:  Reprod Biol Endocrinol       Date:  2016-06-29       Impact factor: 5.211

7.  Cost-effectiveness of GnRH antagonist implementation on hCG injection day.

Authors:  Ayşe Zehra Özdemir; Bülent Ayas; Davut Güven; Aysın Pınar Türkmen; Çağrı Gülümser
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

8.  Mechanisms underlying the tissue-specific and regulated activity of the Gnrhr promoter in mammals.

Authors:  Anne-Laure Schang; Bruno Quérat; Violaine Simon; Ghislaine Garrel; Christian Bleux; Raymond Counis; Joëlle Cohen-Tannoudji; Jean-Noël Laverrière
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-13       Impact factor: 5.555

9.  Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.

Authors:  Jung-Chien Cheng; Christian Klausen; Peter C K Leung
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Transcription factors GATA-4 and GATA-6: molecular characterization, expression patterns and possible functions during goose (Anser cygnoides) follicle development.

Authors:  Xin Yuan; Lu Xia; Xia Dong; Shenqiang Hu; Yingying Zhang; Fang Ding; Hehe Liu; Liang Li; Jiwen Wang
Journal:  J Reprod Dev       Date:  2014-02-17       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.